Monday, November 24, 2025
Monday, November 24, 2025

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin -- the go-to primary drug for glucose management -- to control their blood sugar levels. But adherence to these second-line drugs can be hit or miss, reports a new study.  Among patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), half (50%) discontinued treatment. 
Read more …Nearly 40% of Type 2 diabetes patients stop taking their second-line medication

More Articles …

  1. Calls for police to investigate mental health deaths in Norfolk and Suffolk
  2. Clinical trial demonstrates that the ketogenic diet is effective at controlling polycystic kidney disease
  3. Clues to preventing Alzheimer's come from patient who, despite genetics, evaded disease
  4. Researchers find promising candidate to treat irreversible lung and eye diseases in extremely premature infants
  5. Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain
  6. Defending Eat Out to Help Out - PM's day at Covid inquiry
Page 1621 of 1889